Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L White

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 1, 1979
A chemical mechanism for tissue staining by osmium tetroxide-ferrocyanide mixturesD L White, J E Mazurkiewicz, R J Barrnett
Clinical Pharmacology and Therapeutics|October 11, 2013
Interaction of the efflux transporters ABCB1 and ABCG2 with imatinib, nilotinib, and dasatinibL N Eadie, T P Hughes, D L White
Leukemia|July 1, 2015
OCT1 and imatinib transport in CML: is it clinically relevant?D B Watkins, T P Hughes, D L White
Journal of Musculoskeletal & Neuronal Interactions|March 11, 2005
Micro CT and Micro MR imaging of 3D architecture of animal skeletonY Jiang, J Zhao, D L White, et al.
Nature Communications|April 15, 2018
Shallow magma diversions during explosive diatreme-forming eruptionsNicolas Le Corvec, James D Muirhead, James D L White
Journal of Medicinal Chemistry|January 1, 1988
Specific sequestering agents for the actinides. 16. Synthesis and initial biological testing of polydentate oxohydroxypyridinecarboxylate ligandsD L White, P W Durbin, N Jeung, et al.
Journal of the American College of Nutrition|December 1, 1988
Juvenile hypocalcemia provokes persistent electroencephalographic change in renally compromised ratsJ J Lipman, D L White, P L Lawrence, et al.
Leukemia|July 14, 2012
NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisisD B Watkins, T P Hughes, D L White, et al.
Magnetic Resonance in Medicine|February 1, 1991
Hepatic transport of the magnetic resonance imaging contrast agent Fe(III)-N-(3-phenylglutaryl)desferrioxamine BB A Hoener, A A Tzika, B L Englestad, et al.
Investigative Radiology|September 1, 1990
Magnetic resonance imaging contrast enhancement versus tissue gadolinium concentrationS C Wang, D L White, J M Pope, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 1, 1979
A chemical mechanism for tissue staining by osmium tetroxide-ferrocyanide mixturesD L White, J E Mazurkiewicz, R J Barrnett
Clinical Pharmacology and Therapeutics|October 11, 2013
Interaction of the efflux transporters ABCB1 and ABCG2 with imatinib, nilotinib, and dasatinibL N Eadie, T P Hughes, D L White
Leukemia|July 1, 2015
OCT1 and imatinib transport in CML: is it clinically relevant?D B Watkins, T P Hughes, D L White
Journal of Musculoskeletal & Neuronal Interactions|March 11, 2005
Micro CT and Micro MR imaging of 3D architecture of animal skeletonY Jiang, J Zhao, D L White, et al.
Nature Communications|April 15, 2018
Shallow magma diversions during explosive diatreme-forming eruptionsNicolas Le Corvec, James D Muirhead, James D L White
Journal of Medicinal Chemistry|January 1, 1988
Specific sequestering agents for the actinides. 16. Synthesis and initial biological testing of polydentate oxohydroxypyridinecarboxylate ligandsD L White, P W Durbin, N Jeung, et al.
Journal of the American College of Nutrition|December 1, 1988
Juvenile hypocalcemia provokes persistent electroencephalographic change in renally compromised ratsJ J Lipman, D L White, P L Lawrence, et al.
Leukemia|July 14, 2012
NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisisD B Watkins, T P Hughes, D L White, et al.
Magnetic Resonance in Medicine|February 1, 1991
Hepatic transport of the magnetic resonance imaging contrast agent Fe(III)-N-(3-phenylglutaryl)desferrioxamine BB A Hoener, A A Tzika, B L Englestad, et al.
Investigative Radiology|September 1, 1990
Magnetic resonance imaging contrast enhancement versus tissue gadolinium concentrationS C Wang, D L White, J M Pope, et al.
Pageof 10